• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsAquestive Therapeutics
    Picture of Aquestive Therapeutics logo

    AQST — Aquestive Therapeutics News Story

    $4.710.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    • Market Cap
      $590.87m
    • Enterprise Value
      $608.89m
    • Revenue
      $44.55m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AQST Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AQST Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

    Picture of Aquestive Therapeutics logoAquestive Therapeutics
    02/02/2026 11:55
    NASDAQ TRADE HALT  AQST.O  HALT NEWS PENDING AT 06:55 AM
    

    Recent news on Aquestive Therapeutics

    See all news
    • Brief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing

      13/05/2026 22:56
    • Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income

      13/05/2026 21:18
    • Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film

      30/03/2026 14:47
    • Aquestive misses Q4 revenue estimates, EBITDA loss widens

      04/03/2026 21:22
    • Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million

      04/03/2026 21:01

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.